Case Report: Repeated Series of Ketamine Infusions in Patients With Treatment-Resistant Depression: Presentation of Five Cases

Purpose: Approximately 30% of patients with major depressive disorder (MDD) are treatment resistant. There is an unquestionable need for new treatment strategies. Subanesthetic doses of intravenous (IV) ketamine have a rapid antidepressant effect in treatment-resistant depression (TRD). This paper d...

Descripción completa

Detalles Bibliográficos
Autores principales: Gałuszko-Wȩgielnik, Maria, Włodarczyk, Adam, Cubała, Wiesław Jerzy, Wilkowska, Alina, Górska, Natalia, Słupski, Jakub
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674554/
https://www.ncbi.nlm.nih.gov/pubmed/34925081
http://dx.doi.org/10.3389/fpsyt.2021.705190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674554/
https://www.ncbi.nlm.nih.gov/pubmed/34925081
http://dx.doi.org/10.3389/fpsyt.2021.705190

Ejemplares similares